taurine has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Sande, M | 1 |
| Van Camp, K | 1 |
1 other study available for taurine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Free amino acids and ninhydrin-reacting compounds of median and lateral lobes in human benign prostatic hypertrophy.
Topics: Amino Acids; Glutamates; Humans; Male; Prostatic Hyperplasia; Proteins; Taurine | 1979 |